Clinical Trial Update: Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D) [Phase 1]

View source ↗

Summary

Phase 1 open-label pharmacokinetic trial of iron isomaltoside 1000 (Monofer) given as a single bolus in adults with stage 5 chronic kidney disease on dialysis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Chronic Kidney Disease | Phase 1 | Status: COMPLETED